Inovio Pharmaceuticals, Inc. (BMV:INO)

Inovio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24.35	65.81	14.31	46.33	71.14	250.73
Short-Term Investments	23.2	28.3	130.98	206.67	330.17	160.91
Cash & Short-Term Investments	47.55	94.11	145.29	253	401.31	411.64
Cash Growth	-56.94%	-35.23%	-42.57%	-36.96%	-2.51%	359.76%
Accounts Receivable	-	-	-	1.7	5.47	18.56
Other Receivables	0.84	1.2	2.41	10.04	2.57	0.5
Total Trade Receivables	0.84	1.2	2.41	11.74	8.03	19.06
Other Current Assets	4.31	2.52	5.41	50.51	39.1	40.46
Total Current Assets	52.7	97.83	153.11	315.24	448.44	471.17
Net Property, Plant & Equipment	10.45	11.77	14.45	17.96	29.02	24.09
Other Intangible Assets	-	-	-	2.13	2.63	3.15
Goodwill	-	-	-	10.51	10.51	10.51
Long-Term Investments	3.09	1.61	2.78	2.01	3.91	4.89
Other Long-Term Assets	2.01	1.98	0.61	0.68	1.43	25.96
Total Assets	68.24	113.2	170.95	348.53	495.94	539.77
Accounts Payable	16.12	17.55	20.92	80.91	48.19	21.85
Accrued Expenses	1.51	2.02	2.37	10.59	10.33	9.95
Short-Term Debt	-	-	16.77	-	-	-
Current Portion of Leases	2.66	2.5	2.41	2.8	2.6	2.33
Unearned Revenue	-	-	-	-	0.02	0.05
Other Current Liabilities	11.42	13.26	0.11	2.56	4.6	7.53
Total Current Liabilities	31.71	35.33	42.57	96.87	65.74	41.71
Long-Term Debt	-	-	-	16.61	14.96	18.66
Long-Term Leases	8	9.37	11.03	12.66	15.46	18.06
Other Long-Term Liabilities	-	-	-	0.03	0.11	0.21
Total Long-Term Liabilities	8	9.37	11.03	29.3	30.53	36.93
Total Liabilities	39.71	44.69	53.6	126.17	96.27	78.63
Common Stock	0.04	0.04	0.02	0.02	0.22	0.19
Additional Paid-in Capital	1,803	1,799	1,741	1,711	1,610	1,367
Accumulated Other Comprehensive Income	-0.66	-0.68	-0.66	-0.7	-0.28	-0.26
Retained Earnings	-1,773	-1,730	-1,623	-1,488	-1,210	-906.2
Total Common Shareholders' Equity	28.53	68.5	117.35	222.36	399.67	461.14
Shareholders' Equity	28.53	68.5	117.35	222.36	399.67	461.14
Total Liabilities & Equity	68.24	113.2	170.95	348.53	495.94	539.77
Total Debt	10.66	11.87	30.21	32.07	33.02	39.05
Net Cash (Debt)	36.89	82.25	115.08	220.92	368.29	372.59
Net Cash Growth	-55.15%	-28.53%	-47.91%	-40.01%	-1.16%	-
Net Cash Per Share	1.09	3.03	5.19	11.11	21.16	28.82
Book Value	28.53	68.5	117.35	222.36	399.67	461.14
Book Value Per Share	0.84	2.52	5.29	11.18	22.97	35.67
Tangible Book Value	28.53	68.5	117.35	209.72	386.53	447.48
Tangible Book Value Per Share	0.84	2.52	5.29	10.55	22.21	34.62

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.